NCT02293746 - Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 11, 2016

Study Completion Date

January 9, 2017

Conditions

Obstructive Sleep Apnea

Interventions

DEVICE

Inspire® Upper Airway Stimulation (UAS) System

This is a single-arm study; all participants will be implanted with the Inspire® Upper Airway Stimulation (UAS) System is a permanent, implantable therapy device, which consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the patient receives a remove to activate the therapy.

Trial Locations (3)

23538

Klinik für HNO-Heilkunde/HNO-Schlaflabor, Lübeck

D-68135

Universitäts-HNO-Klinik Mannheim, Mannheim

D-81675

Klinikum rechts der Isar der Technischen Universität München, München